Author of the publication

Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease

, , , , , , , , , , , , , , , , , , , , , , , , and . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 (6): 2275–2287 (1997)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group, , , , , , , , , and 15 other author(s). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, (1998)Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone, , , , , , , , , and 19 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 (11): 2905–2914 (2001)Resonances and emission patterns of optical microdisk resonators with scatterers., , and . ICTON, page 1-4. IEEE, (2015)Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG), , , , , , , , , and . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 6 (9): 901–910 (1995)BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group, , , , , , , , , and 15 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 (12): 3810–3821 (1998)Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial, , , , , , , , , and 21 other author(s). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 15 (2): 276–282 (2004)BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group, , , , , , , , , and 1 other author(s). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 8 (2): 143–148 (1997)Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group, , , , , , , , , and 10 other author(s). Blood, 92 (12): 4560–4567 (1998)Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease, , , , , , , , , and 15 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 (6): 2275–2287 (1997)Colorectal cancer atlas: An integrative resource for genomic and proteomic annotations from colorectal cancer cell lines and tissues., , , , , , , , , and 5 other author(s). Nucleic Acids Res., 44 (Database-Issue): 969-974 (2016)